Prospective cohort study integrating plasma proteomics and machine learning for early risk prediction of prostate cancer.
Journal:
International journal of surgery (London, England)
Published Date:
Jun 25, 2025
Abstract
BACKGROUND: Early detection of prostate cancer (PCa) remains a clinical challenge. Plasma proteomics provides a non-invasive tool for identifying individuals at elevated risk prior to symptom onset or PSA elevation.
Authors
Keywords
No keywords available for this article.